Azenta Life Sciences Completes Sale of Semiconductor Solutions Group Business to Thomas H. Lee Partners February 1, 2022 CHELMSFORD, Mass., Feb. 1, 2022 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has completed the previously announced sale of the company's Semiconductor Solutions Group business (or "automation business") to Thomas H. Lee Partners ("THL") for $3.0 billion in cash, subject to adjustments for working capital and other items.
Azenta Life Sciences Expands Fleet of PacBio HiFi Sequencing Systems January 6, 2022 Press Releases MENLO PARK, Calif., Jan 6, 2022 - PacBio (Nasdaq: PACB) today announced an expansion of its extensive suite of HiFi applications with Azenta Life Sciences, formerly GENEWIZ.
Azenta Life Sciences Announces New Agreement with QTC Management, Inc. to Support the Military Reserve Health Readiness Program November 8, 2021 Press Releases Chelmsford, Mass., Nov. 8, 2021 - Azenta Life Sciences has been contracted by QTC Management, Inc., a Leidos company (NYSE: LDOS), to provide the storage and distribution of vaccines to the U.S. Department of Defense.
Azenta Life Sciences and Cleveland Clinic Celebrate Opening of Biobanking Facility October 7, 2021 Press Releases Azenta Life Sciences and Cleveland Clinic have opened a new 22,000-square-foot biospecimen sample management and repository facility on Cleveland Clinic’s main campus. The 22,000-square-foot ultra-cold and cryogenic storage facility will enhance researchers’ study to accelerate breakthroughs and optimize patient care.
Brooks Introduces Azenta Life Sciences to Advance Innovative Sample Solutions September 28, 2021 Press Releases New life sciences brand enables breakthroughs to market with a fully integrated portfolio for unparalleled sample exploration and management solutions
Brooks Announces Intention to Separate Into Two Independent Publicly Traded Companies May 11, 2021 Press Releases Brooks announces intention to separate into two independent publicly traded companies. The transaction is intended to be structured as a pro-rata distribution of shares to Brooks shareholders in a tax-efficient manner.
Azenta Life Sciences and GENEWIZ to Host 2-Day Virtual Event Focused on Cell and Gene Therapy April 7-8, 2021 April 6, 2021 Press Releases South Plainfield, NJ (April 6, 2021) – The Advancing CGT Virtual Event presented by GENEWIZ and Azenta Life Sciences, opens on April 7-8, 2021 and aims to discuss the opportunities, challenges, and latest technology breakthroughs in cell and gene therapy. This free, 2-day meeting offers a platform for industry leaders and researchers from across the globe to present some of the latest research and solutions surrounding cell and gene therapy.
Cytiva and Azenta Life Sciences to Enhance Automation in Cold Chain Solutions February 15, 2021 Press Releases By integrating BioStore III with Cytiva’s Chronicle software, we are helping customers add the documented rigor around cold chain, inventory and handling which previously did not exist.
Azenta Life Sciences Announces GENEWIZ Selected as Genome Characterization Center by the National Cancer Institute January 12, 2021 Press Releases NCI, the nation’s leader in cancer research, chooses GENEWIZ to provide whole exome sequencing to new research projects at its Center for Cancer Genomics.
Azenta Life Sciences Announces the Acquisition of Trans-Hit Biomarkers December 18, 2020 Press Releases We are pleased to announce that Azenta Life Sciences has completed the acquisition of Trans-Hit Bio, a company with deep expertise in the biospecimen sourcing space.